Vera Therapeutics, Inc. - Class A Common Stock — Liquidità (NASDAQ:VERA) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -23.71 M-67.6 M-92.18 M-134.68 M-241.1 M -293.2 M Flussi di cassa derivanti dalle attività di investimento -4.2 M-70.55 M-39.43 M-425.03 M194.29 M 41.15 M Liquidità derivante dalle attività di finanziamento 53.88 M101.93 M133.54 M606.67 M308.9 M 311.31 M Liquidità libera -23.71 M-67.6 M-92.18 M-134.68 M-241.73 M -293.66 M

Notizie

Vera Therapeutics: Strong IgAN Data, But Differentiation Is Still Pending (NASDAQ:VERA)

Vera Therapeutics alla prova degli utili prima del verdetto FDA

Vera Therapeutics nomina Jane Wright-Mitchell direttrice legale

Wolfe Research alza il rating di Vera Therapeutics sulla base della valutazione

Wolfe Research upgrades Vera Therapeutics stock rating on valuation

BofA Securities conferma rating Buy su Vera Therapeutics

Vera Therapeutics stock rating reaffirmed at Buy by BofA Securities

Vera Therapeutics, Inc. (VERA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Vera Therapeutics adds Christopher Hite to board of directors

3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026 - TipRanks.com

Vera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade)

VeraDermics is said to draw IPO anchor order from Eli Lilly - Bloomberg